Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2003
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091669 Mixture saponin, sugars and protein; solvent extraction, drying, sterilization; brain disorders, Alzheimer's disease
05/15/2003US20030091645 Organic compounds
05/15/2003US20030091635 Sustained release; reduced tendency to drug abruse
05/15/2003US20030091631 Method of providing sustained analgesia with buprenorphine
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091620 Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same
05/15/2003US20030091614 Compositions normalizing circadian rhythm
05/15/2003US20030091611 Antiproliferative agents ; antiinflammatory agents; insertable stent
05/15/2003US20030091595 West nile vaccine
05/15/2003US20030091578 Multiple sclerosis; rheumatic diseases; vaccine
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091570 Analgesics; antiinflammatory agents; analyzing drug as to ability to modulation gene expression
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein
05/15/2003US20030091505 Antiserotonine agents; central nervous system disorders
05/15/2003CA2789407A1 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2472097A1 Antisense modulation of purinoreceptor p2x3
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
05/15/2003CA2466336A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
05/15/2003CA2466334A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003CA2466303A1 Selective targeting of apoptotic cells
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies
05/15/2003CA2466145A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003CA2466033A1 Method of treating disorder related to high cholesterol concentration
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2465981A1 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003CA2465952A1 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003CA2465920A1 Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory
05/15/2003CA2465753A1 Orodispersible tablet having high homogeneity and the preparation method thereof
05/15/2003CA2465713A1 Derivatives of phenoxy-n-'4-(1,1-dioxoisothiazolidin-2-yl)phenyl!-valeramide and other compounds as inhibitors of coagulation factor xa for the treatment of thromboembolic diseases and tumours
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003CA2465496A1 Oral controlled release forms useful for reducing or preventing nicotine cravings
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2465186A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2464528A1 Pharmaceutical composition
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/14/2003EP1310797A2 Method of monitoring neuroprotective treatment
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310494A1 PPAR (delta) ACTIVATORS
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310482A1 Prodrugs of excitatory amino acids
05/14/2003EP1310480A1 Prodrugs of excitatory amino acids
05/14/2003EP1310258A1 Enantiomers of steroids for the enhancement of memory and cognitive function
05/14/2003EP1310248A1 Pharmaceutical composition
05/14/2003EP1309721A2 Modulating multiple lineage kinase proteins
05/14/2003EP1309706A2 Modulation of stem cell differentiation
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309700A2 Human phosphodiesterases
05/14/2003EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309626A2 Cng2b: a putative human cyclic nucleotide-gated ion channel
05/14/2003EP1309618A2 Leucine-based motif and clostridial neurotoxins
05/14/2003EP1309613A2 Pharmaceutical composition comprising an analgesic peptide
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309586A1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
05/14/2003EP1309582A1 Method for the preparation of citalopram
05/14/2003EP1309581A1 Method for the preparation of citalopram
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309553A1 New aporphine esters and their use in therapy
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309551A1 Indoline derivatives as 5ht2c antagonists
05/14/2003EP1309544A1 Compounds acting as melanocortin receptor ligands
05/14/2003EP1309373A2 Method and composition for altering a t cell mediated pathology
05/14/2003EP1309354A2 Therapeutic polyesters and polyamides
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309341A2 Prevention and treatment of alzheimer's disease
05/14/2003EP1309337A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage
05/14/2003EP1309335A1 Use of extracts from ginkgo biloba leaves for inducing dreams
05/14/2003EP1309334A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/14/2003EP1309325A1 Anticonvulsant derivatives useful for the treatment of depression
05/14/2003EP1309322A2 Method of treating neurodegenerative disorders of the retina and optic nerve head
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1233953B1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP1107967B1 Triazolopyridazine derivatives for enhancing cognition
1 ... 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 ... 1833